<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38081327</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1678-4391</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases</Title><ISOAbbreviation>Braz J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Comparative analysis of SARS-CoV-2 variants Alpha (B.1.1.7), Gamma (P.1), Zeta (P.2) and Delta (B.1.617.2) in Vero-E6 cells: ultrastructural characterization of cytopathology and replication kinetics.</ArticleTitle><Pagination><StartPage>103706</StartPage><MedlinePgn>103706</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">103706</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjid.2023.103706</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1413-8670(23)00966-2</ELocationID><Abstract><AbstractText>This study compares the effects of virus-cell interactions among SARS-CoV-2 variants of concern (VOCs) isolated in Brazil in 2021, hypothesizing a correlation between cellular alterations and mortality and between viral load and transmissibility. For this purpose, reference isolates of Alpha, Gamma, Zeta, and Delta variants were inoculated into monolayers of Vero-E6 cells. Viral RNA was quantified in cell supernatants by RT‒PCR, and infected cells were analyzed by Transmission Electron Microscopy (TEM) for qualitative and quantitative evaluation of cellular changes 24, 48, and 72 hours postinfection (hpi). Ultrastructural analyses showed that all variants of SARS-CoV-2 altered the structure and function of mitochondria, nucleus, and rough endoplasmic reticulum of cells. Monolayers infected with the Delta variant showed the highest number of modified cells and the greatest statistically significant differences compared to those of other variants. Viral particles were observed in the cytosol and the cell membrane in 100 % of the cells at 48 hpi. Alpha showed the highest mean particle diameter (79 nm), and Gamma and Delta were the smallest (75 nm). Alpha and Gamma had the highest particle frequency per field at 48 hpi, while the same was observed for Zeta and Delta at 72 hpi and 24 hpi, respectively. The cycle threshold of viral RNA varied among the target protein, VOC, and time of infection. The findings presented here demonstrate that all four VOCs evaluated caused ultrastructural changes in Vero-E6 cells, which were more prominent when infection occured with the Delta variant.</AbstractText><CopyrightInformation>Copyright © 2023 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vieira</LastName><ForeName>Debora Ferreira Barreto</ForeName><Initials>DFB</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz (Fiocruz), Instituto Oswaldo Cruz, Laboratório de Morfologia e Morfogênese Viral, Rio de Janeiro, RJ, Brazil. Electronic address: barreto@ioc.fiocruz.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bandeira</LastName><ForeName>Derick Mendes</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz (Fiocruz), Instituto Oswaldo Cruz, Laboratório de Morfologia e Morfogênese Viral, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Marcos Alexandre Nunes</ForeName><Initials>MAN</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz (Fiocruz), Instituto Oswaldo Cruz, Laboratório de Morfologia e Morfogênese Viral, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Almeida</LastName><ForeName>Ana Luisa Teixeira</ForeName><Initials>ALT</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz (Fiocruz), Instituto Oswaldo Cruz, Laboratório de Morfologia e Morfogênese Viral, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Araújo</LastName><ForeName>Mia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz (Fiocruz), Instituto Oswaldo Cruz, Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado</LastName><ForeName>Ana Beatriz</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz (Fiocruz), Instituto Oswaldo Cruz, Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tort</LastName><ForeName>Luis Fernando Lopez</ForeName><Initials>LFL</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz (Fiocruz), Instituto Oswaldo Cruz, Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Rio de Janeiro, RJ, Brazil; Universidad de la República, Centro Universitario Regional - Litoral Norte, Laboratório de Virologia Molecular, Departamento de Ciências Biológicas, Salto, Uruguai.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nacife</LastName><ForeName>Valéria Pereira</ForeName><Initials>VP</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz (Fiocruz), Instituto Oswaldo Cruz, Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siqueira</LastName><ForeName>Marilda M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz (Fiocruz), Instituto Oswaldo Cruz, Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motta</LastName><ForeName>Fernando Couto</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz (Fiocruz), Instituto Oswaldo Cruz, Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pauvolid-Corrêa</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz (Fiocruz), Instituto Oswaldo Cruz, Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Rio de Janeiro, RJ, Brazil; Universidade Federal de Viçosa, Departamento de Veterinária, Laboratório de Virologia Veterinária de Viçosa, Viçosa, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barth</LastName><ForeName>Ortrud Monika</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz (Fiocruz), Instituto Oswaldo Cruz, Laboratório de Morfologia e Morfogênese Viral, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Infect Dis</MedlineTA><NlmUniqueID>9812937</NlmUniqueID><ISSNLinking>1413-8670</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093222" MajorTopicYN="Y">Cytology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brazil</Keyword><Keyword MajorTopicYN="N">Cytopathology</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Transmission electron microscopy</Keyword><Keyword MajorTopicYN="N">Ultrastructural studies</Keyword><Keyword MajorTopicYN="N">Variant of concern</Keyword><Keyword MajorTopicYN="N">Vero-E6 cells</Keyword></KeywordList><CoiStatement>Conflicts of interest The authors declare no have conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38081327</ArticleId><ArticleId IdType="pmc">PMC10776915</ArticleId><ArticleId IdType="doi">10.1016/j.bjid.2023.103706</ArticleId><ArticleId IdType="pii">S1413-8670(23)00966-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., et al. A novel coronavirus from patients with pneumonia in China, 2019. New England J Med. 2020;382:727–733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization; Geneva: 2020. WHO COVID-19 Dashboard.https://covid19.who.int/ Available online: [cited: August 13, 2023]</Citation></Reference><Reference><Citation>Morens D.M., Fauci A.S. Emerging pandemic diseases: how we got to COVID-19. Cell. 2020;182:1077–1092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7428724</ArticleId><ArticleId IdType="pubmed">32846157</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo P.C.Y., de Groot R.J., Haagmans B., Lau S.K.P., Neuman B.W., Perlman S., et al. ICTV virus taxonomy profile: coronaviridae 2023. J Gen Virol. 2023;104(4)</Citation><ArticleIdList><ArticleId IdType="pubmed">37097842</ArticleId></ArticleIdList></Reference><Reference><Citation>Callaway E. The coronavirus is mutating - does it matter? Nature. 2020;585:174.</Citation><ArticleIdList><ArticleId IdType="pubmed">32901123</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasian M.H., Mahmanzar M., Rahimian K., Mahdavi B., Tokhanbigli S., Moradi B., et al. Global landscape of SARS-CoV-2 mutations and conserved regions. J Transl Med. 2023;21:152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9958328</ArticleId><ArticleId IdType="pubmed">36841805</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Disease (COVID-19): Variants of SARS-CoV-2 [internet]. World Health Organization: WHO. 2021 [cited October 30, 2023]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-%28covid-19%29-variants-of-sars-cov-2?gclid=EAIaIQobChMIv_zf6-ieggMVSuXjBx3E3QCmEAAYASAAEgIw1_D_BwE.</Citation></Reference><Reference><Citation>Winger A., Caspari T. The spike of concern-the novel variants of SARS-CoV-2. Viruses. 2021;13:1002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8229995</ArticleId><ArticleId IdType="pubmed">34071984</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelon C.M. Main SARS-CoV-2 variants notified in Brazil. Rev Bras Anál Clín. 2021;53:109–116.</Citation></Reference><Reference><Citation>Tang J.W., Tambyah P.A., Hui D.S. Emergence of a new SARS-CoV-2 variant in the UK. J Infect. 2021;82:e27–e28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834693</ArticleId><ArticleId IdType="pubmed">33383088</ArticleId></ArticleIdList></Reference><Reference><Citation>Han P., Su C., Zhang Y., Bai C., Zheng A., Qiao C., et al. Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants. Nat Commun. 2021;12:6103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8528823</ArticleId><ArticleId IdType="pubmed">34671049</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P., Bell I., Breuer J., et al.   GOV.UK; 2021. NERVTAG: Update note On B.1.1.7 Severity.https://www.gov.uk/government/publications/nervtag-update-note-on-b117-severity-11-february-2021 11 February.</Citation></Reference><Reference><Citation>Gu H., Chen Q., Yang G., He L., Fan H., Deng Y.-Q., et al. Adaptation of SARSCoV-2 in BALB/c mice for testing vaccine efficacy. Science. 2020;369:1603–1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7574913</ArticleId><ArticleId IdType="pubmed">32732280</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujino T., Nomoto H., Kutsuna S., Ujiie M., Suzuki T., Sato R., et al. Novel SARS-CoV-2 variant in travelers from Brazil to Japan. Emerging Infect Dis. 2021;27:1243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007308</ArticleId><ArticleId IdType="pubmed">33567247</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria N.R., Mellan T.A., Whittaker C., Claro I.M., Candido D.D., Mishra S., et al. Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil. Science. 2021;372:815–821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8139423</ArticleId><ArticleId IdType="pubmed">33853970</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton M.I., MacGowan S.A., Kutuzov M.A., Dushek O., Barton G.J., et al. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Elife. 2021;10:e70658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8480977</ArticleId><ArticleId IdType="pubmed">34435953</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano C.M., Felix A.C., Paula A.V., Jesus J.G., Andrade P.S., Cândido D., et al. SARS-CoV-2 reinfection caused by the P. 1 lineage in Araraquara city, Sao Paulo State, Brazil. Rev Inst Med Trop Sao Paulo. 2021;63:e36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075619</ArticleId><ArticleId IdType="pubmed">33909850</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeiser F.A., Donida B., da Costa C.A., de Oliveira Ramos G., Scherer J.N., Barcellos N.T., et al. First and second COVID-19 waves in Brazil: a cross-sectional study of patients’ characteristics related to hospitalization and in-hospital mortality. Lancet Reg Health Am. 2022;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8557995</ArticleId><ArticleId IdType="pubmed">34746913</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., Shaman J. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination. J R Soc Interface. 2022;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9169547</ArticleId><ArticleId IdType="pubmed">35670221</ArticleId></ArticleIdList></Reference><Reference><Citation>Galmiche S., Cortier T., Charmet T., Schaeffer L., Chény O., von Platen C., et al. SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study. Lancet Microbe. 2023;4:e409–e417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10112864</ArticleId><ArticleId IdType="pubmed">37084751</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Deng A., Li K., Hu Y., Li Z., Shi Y., et al. Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant. Nat Commun. 2022;13:460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786931</ArticleId><ArticleId IdType="pubmed">35075154</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Wei P., Zhang Q., Aviszus K., Linderberger J., Yang J., et al. The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines. BioRxiv. 2021 doi: 10.1101/2021.08.25.457692. Preprint.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.08.25.457692</ArticleId></ArticleIdList></Reference><Reference><Citation>Voloch C.M., da Silva Francisco Jr R., de Almeida L.G., Cardoso C.C., Brustolini O.J., et al. COVID-19 - UFRJ Workgroup. Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil. J Virol. 2021;95:10–128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8139668</ArticleId><ArticleId IdType="pubmed">33649194</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Epidemiological update: variants of SARS-CoV-2 in the Americas. 2021 Mar [cited 2023 Jul 26] https://iris.paho.org/bitstream/handle/10665.2/53382/EpiUpdate24March2021_eng.pdf?sequence=1&amp;isAllowed=y.</Citation></Reference><Reference><Citation>Mohammadi M., Shayestehpour M., Mirzaei H. The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines. Braz J Infect Dis. 2021;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8367756</ArticleId><ArticleId IdType="pubmed">34428473</ArticleId></ArticleIdList></Reference><Reference><Citation>Resende P.C., Bezerra J.F., Vasconcelos R.H., Arantes I., Appolinario L., Mendonça A.C., et al. Severe acute respiratory syndrome coronavirus 2 P 2 lineage associated with reinfection case, Brazil, June–October 2020. Emerg Infect Dis. 2021;27:1789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8237896</ArticleId><ArticleId IdType="pubmed">33883059</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva M.S., Demoliner M., Hansen A.W., Gularte J.S., Silveira F., Heldt F.H., et al. Early detection of SARS-CoV-2 P 1 variant in Southern Brazil and reinfection of the same patient by P. 2. Rev Instit Med Trop Sao Paulo. 2021;63:e58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8266303</ArticleId><ArticleId IdType="pubmed">34231823</ArticleId></ArticleIdList></Reference><Reference><Citation>Mautner L., Hoyos M., Dangel A., Berger C., Ehrhardt A., Baiker A. Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models. Virol J. 2022;19 1-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9038516</ArticleId><ArticleId IdType="pubmed">35473640</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahlmann N.A., Mautner L., Hoyos M., Sallard E., Berger C., Dangel A., et al. In Vitro analysis of the effect of SARS-CoV-2 non-VOC and four variants of concern on MHC-class-I expression on Calu-3 and Caco-2 cells. Genes. 2023;14:1348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10378856</ArticleId><ArticleId IdType="pubmed">37510253</ArticleId></ArticleIdList></Reference><Reference><Citation>Mautner L., Hoyos M., Dangel A., Berger C., Ehrhardt A., Baiker A. Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models. Virol J. 2022;19:76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9038516</ArticleId><ArticleId IdType="pubmed">35473640</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsmith C.S., Miller S.E. Modern uses of electron microscopy for detection of viruses. Clin Microbiol Rev. 2009;22:552–563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772359</ArticleId><ArticleId IdType="pubmed">19822888</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveca F.G., Nascimento V., de Souza V.C., Corado A.L., Nascimento F., Silva G., et al. 2021. COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence. Nat Med. 2021;27:1230–1238.</Citation><ArticleIdList><ArticleId IdType="pubmed">34035535</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth O.M., da Silva M.A.N., Barreto-Vieira D.F. Low impact to fixed cell processing aiming transmission electron microscopy. Mem Inst Oswaldo Cruz. 2016;111:411–413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4909042</ArticleId><ArticleId IdType="pubmed">27276186</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye M., Druce J., Tran T., Kostecki R., Chibo D., Morris J., et al. SARS – associated coronavirus replication in cell lines. Emerg Infect Dis. 2006;12:128–133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3291385</ArticleId><ArticleId IdType="pubmed">16494729</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreto-Vieira D.F., da Silva M.A.N., Garcia C.C., Miranda M.D., Matos A.D.R., Caetano B.C., et al. Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells. Mem Inst Oswaldo Cruz. 2021;116</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7874846</ArticleId><ArticleId IdType="pubmed">33566951</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreto-Vieira D.F., da Silva M.A.N., de Almeida A.L.T., Rasinhas A.D.C., Monteiro M.E., Miranda M.D., et al. SARS-CoV-2: ultrastructural characterization of morphogenesis in an in vitro system. Viruses. 2022;14:201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8879486</ArticleId><ArticleId IdType="pubmed">35215794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouhpayeh S., Shariati L., Boshtam M., Rahimmanesh I., Mirian M., Esmaeili Y., et al. The molecular basis of COVID-19 pathogenesis, conventional and nanomedicine therapy. Inter J Mol Sci. 2021;22:5438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8196740</ArticleId><ArticleId IdType="pubmed">34064039</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang C., Liu Z., Zhu Y., Lu J., Ge C., Zhang C., et al. SARS-CoV-2 causes mitochondrial dysfunction and mitophagy impairment. Front Microbiol. 2022;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8770829</ArticleId><ArticleId IdType="pubmed">35069483</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., Ptacek R., Ptackova H., Martin A., Kream R.M. Selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce 'brain fog' and results in behavioral changes that favor viral survival. Med Sci Monit. 2021;27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7845145</ArticleId><ArticleId IdType="pubmed">33487628</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran K., Maity S., Muthukumar A.R., Kandala S., Tomar D., Abd El-Aziz T.M., et al. SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics. iScience. 2022;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8720045</ArticleId><ArticleId IdType="pubmed">35005527</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Wu Y., Meng X., Wang Z., Younis M., Liu Y., et al. SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK. Cell Death Differ. 2022;29:1395–1408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8752586</ArticleId><ArticleId IdType="pubmed">35022571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackstadt T., Chiramel A.I., Hoyt F.H., Williamson B.N., Dooley C.A., Beare P.A., et al. Disruption of the golgi apparatus and contribution of the endoplasmic reticulum to the SARS-CoV-2 replication complex. Viruses. 2021;13:1798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8473243</ArticleId><ArticleId IdType="pubmed">34578379</ArticleId></ArticleIdList></Reference><Reference><Citation>Roingeard P., Eymieux S., Burlaud-Gaillard J., Hourioux C., Patient R., Blanchard E. The double-membrane vesicle (DMV): a virus-induced organelle dedicated to the replication of SARS-CoV-2 and other positive-sense single-stranded RNA viruses. Cell Mol Life Sci. 2022;79:425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9287701</ArticleId><ArticleId IdType="pubmed">35841484</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T., Hirschenberger M., et al. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science. 2020;369:1249–1255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402621</ArticleId><ArticleId IdType="pubmed">32680882</ArticleId></ArticleIdList></Reference><Reference><Citation>Slobodin B., Sehrawat U., Lev A., Hayat D., Zuckerman B., Fraticelli D., et al. Cap-independent translation and a precisely located RNA sequence enable SARS-CoV-2 to control host translation and escape anti-viral response. Nucleic Acids Res. 2022;50:8080–8092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9371909</ArticleId><ArticleId IdType="pubmed">35849342</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias S.S.G., Soares V.C., Ferreira A.C., Sacramento C.Q., Fintelman-Rodrigues N., Temerozo J.R., et al. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Pathog. 2020;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773323</ArticleId><ArticleId IdType="pubmed">33326472</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatel-Chaix L., Bartenschlager R. Dengue virus-and hepatitis C virus-induced replication and assembly compartments: the enemy inside ‒ caught in the web. J Virol. 2014;88:5907–5911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4093888</ArticleId><ArticleId IdType="pubmed">24623440</ArticleId></ArticleIdList></Reference><Reference><Citation>Baselga M., Moreo E., Uranga-Murillo I., Arias M., Junquera C. Ultrastructural analysis, and three-dimensional reconstruction of cellular structures involved in SARS-CoV-2 spread. Histochem Cell Biol. 2022;29:1–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9521873</ArticleId><ArticleId IdType="pubmed">36175690</ArticleId></ArticleIdList></Reference><Reference><Citation>Oprinca G.C., Oprinca-Muja L.A., Mihalache M., Birlutiu R.M., Birlutiu V. Is SARS-CoV-2 directly responsible for cardiac injury? Clinical aspects and postmortem histopathologic and immunohistochemical analysis. Microorganisms. 2022;10:1258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9323730</ArticleId><ArticleId IdType="pubmed">35888977</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts J., Cheng J.D., Moore E., Ransom C., Ma M., Rogers B.B. Extensive perivillous fibrin and intervillous histiocytosis in a SARS-CoV-2 infected placenta from an uninfected newborn: a case report including immunohistochemical profiling. Pediatr Dev Pathol. 2021;24:581–584.</Citation><ArticleIdList><ArticleId IdType="pubmed">34176361</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Guo S., Yang H. Rapid quantitative monitoring of SARS-CoV-2 spike protein-mediated syncytia formation using split NanoLuc. J Med Virol. 2022;94:6073–6077.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538440</ArticleId><ArticleId IdType="pubmed">35940856</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelardi M., Notargiacomo M., Trecca E.M.C., Cassano M., Ciprandi G. COVID-19: the difference between the nose and the lung. Monaldi Arch Chest Dis. 2021;91(2)</Citation><ArticleIdList><ArticleId IdType="pubmed">33666069</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussani R., Schneider E., Zentilin L., Collesi C., Ali H., Braga L., Volpe M.C., et al. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. EBioMedicine. 2020;61</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7677597</ArticleId><ArticleId IdType="pubmed">33158808</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N., Dingyu Z., Wenling W., Xingwang L., Bo Y., Song J., et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:723–733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajah M.M., Hubert M., Bishop E., Saunders N., Robinot R., Grzelak L., et al. SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation. EMBO J. 2021;40</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646911</ArticleId><ArticleId IdType="pubmed">34601723</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav P., Mohandas S., Sarkale P., Nyayanit D., Shete A., Sahay R., et al. Isolation of SARS-CoV-2 B1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model. J Infect Public Health. 2022;15:164–171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8690136</ArticleId><ArticleId IdType="pubmed">34959053</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiehzadegan S., Alaghemand N., Fox M., Venketaraman V. Analysis of the delta variant B. 1.617. 2 COVID-19. Clin Pract. 2021;11:778–784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8544471</ArticleId><ArticleId IdType="pubmed">34698149</ArticleId></ArticleIdList></Reference><Reference><Citation>Qinfen Z., Jinming C., Xiaojun H., Huanying Z., Jicheng H., Ling F., et al. The life cycle of SARS coronavirus in Vero E6 cells. J Med Virol. 2004;73:332–337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166737</ArticleId><ArticleId IdType="pubmed">15170625</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein S., Cortese M., Winter S.L., Wachsmuth-Melm M., Neufeldt C.J., Cerikan B., et al. SARS-CoV-2 structure, and replication characterized by in situ cryo-electron tomography. Nat Commun. 2020;11:5885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7676268</ArticleId><ArticleId IdType="pubmed">33208793</ArticleId></ArticleIdList></Reference><Reference><Citation>Laue M., Kauter A., Hoffmann T., Möller L., Michel J., Nitsche A. Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures. Sci Rep. 2021;11:3515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876034</ArticleId><ArticleId IdType="pubmed">33568700</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>